An analysis of results from 3 clinical trials demonstrated that pegaspargase is cost-effective, improved quality-adjusted life-years, and was the dominant therapy in comparisons with native asparagine in multiple scenarios.
Researchers suggested several criteria for determining drug value in a survey given to participants for feedback.
The study’s primary endpoint was efficacy, determined by complete remission, peripheral blood cell count remission, quality of life, and JAK2 V617F allele burden.
Parenteral nutrition showed a higher rate of infection than enteral nutrition, according to results of a recent updated literature review and meta-analysis.
Patients’ survey responses ranged from the garments cause discomfort to they alleviate discomfort. Some responses indicated patients face a possible trade-off between comfort and protection in finding the optimal support garment.
Prophylactic antibiotics trended toward reducing infection risk at 3 months if given in first 2 to 3 months after MM diagnosis; however, it had no effect on mortality rates.
In an evaluation of the use of geriatric assessments by specially trained oncology nurses in the care of older patients with cancer, particularly when patients are susceptible to potential loss of autonomy, researchers found physicians often seek nurse assessments.
Although higher nurse-to-patient ratios ensure good outcomes for patients undergoing pancreaticoduodenectomy, PD-specific surgeon volume has a greater effect on risks of complications for these patients.
Risk of death inversely proportionate to volume of patients with advanced-stage malignant melanoma treated at a facility.
An oncology pharmacist sounds off on an issue regarding chemotherapy administration that affects cancer centers worldwide.
